Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dementia: early-phase trial registry
79 of 202 indexed Dementia trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #48 of 28,707 conditions by registered trial count.
202 US clinical trials · 79 currently recruiting · #48 of 28,707 conditions by registered trial count
Dementia: 202 US clinical trials tracked, 79 recruiting.
Dementia is the subject of 202 registered US clinical trials on ClinicalTrials.gov, 79 of them currently open to new participants. 13 are in Phase 3-4 (later-stage) and 29 in Phase 1-2 (earlier-stage). The most active sponsor is University of Washington, running 8 of these trials.
Enrollment posture brief
Registry condition dementia
OPEN 79 | RECR 39% | LATE 13 | EARLY 29 | RANK #48 | SPON 8
Volume-matched condition peers
Nearest open-share peer: Advanced Non-Small-Cell Lung Cancer (39% recruiting · 23 trials)
Dementia lists 79 open slots (39% of 202 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dementia on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dementia is recruiting above its size-band peers.
79 of 202 indexed trials (39.1%) are open to enrollment, against a 37.1% average across 139 conditions with 100+ trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Dementia trials is spread across many organizations.
University of Washington accounts for 8 of 202 trials (4%). 110 distinct sponsors appear on at least one study for this condition label.
-
Typical Dementia enrolment sits around 154 participants.
Median target enrolment is 154 among the 200 trials that report a genuine target (sentinel values excluded). 80 of those (40%) plan for fewer than 100 participants.
-
Dementia research is mostly interventional.
157 interventional and 45 observational studies make up this index (77.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
202 total, page 2 of 5
A Multi-Modal Combination Intervention to Promote Cognitive Function in Older Intensive Care Unit Survivors
University of Washington
NCT06411561
Apolipoprotein E (APOE) Genotype Effects on Triglycerides and Blood Flow in the Human Brain
University of Washington
NCT04692441
Sleep Enhancement for Older Adults Living With Memory Loss And Their Care Partners
Emory University
NCT06250725
Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.
University of Southern California
NCT06418971
Early-Stage Partner in Care Living Alone Plus
Arizona State University
NCT06962111
Caregivers Preparing for Their Own Health Care Emergency
University of California, Davis
NCT06635876
Ferritin and Iron Burden in SAH sIRB
Duke University
NCT03754725
Comparing Structured Retrieval Practice and Reading-Based Education for Dementia Caregivers
Virginia Wesleyan University
NCT07413406
Enhancing Shared Decision-making to Guide Care for People With Dementia and Diabetes
Indiana University
NCT05643144
Clinical Trial Evaluating the Efficacy of AGB101 for Reducing Hippocampal Overactivity in Older Adults
Johns Hopkins University
NCT06919926
Exploration of an Online Education Program to Support Caregivers' Knowledge Transfer
Texas Christian University
NCT07377331
Development of a Personalized, Psychosocial Intervention for Menopausal Individuals With Elevated Dementia Risk
University of Chicago
NCT06965686
Delirium Identification in Older Patients With Alzheimer's and Other Related Dementias In the Emergency Department
Ohio State University
NCT06326424
E-Tailored Pain Management Support for Dementia Family Caregivers: Feasibility of the PACE-app
University of Iowa
NCT07032350
University of Central Florida Music Study
University of Central Florida
NCT07306065
Web-based Cognitive Behavioral Treatment for Insomnia in Dementia Caregivers
University of South Florida
NCT04632628
Cognitive Reserve and Response to Speech-Language Intervention in Bilingual Speakers With Primary Progressive Aphasia
University of Texas at Austin
NCT05741853
Dynamic Light Scattering Ocular Measurement in the Detection of Dementia
MD Stem Cells
NCT06613971
Resilient Together for Dementia (RT-D)
Icahn School of Medicine at Mount Sinai
NCT06619327
Caregiver Bootcamp
Emory University
NCT07006116
DECIDE: Dyads and Families
Emory University
NCT05139290
Community Health Worker-Led Transition Support for Persons Living With Dementia and Caregivers
University of Texas at Austin
NCT06831318
Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside
Mclean Hospital
NCT05245903
Environmental and Sensory Intervention for Nursing Home Residents With Dementia Who Exhibit Persistent Vocalizations
Drexel University
NCT06568107
Combating Alzheimer's Through Sleep and Exercise
University of Miami
NCT04855630
Investigating Dynamic Interactions in Distributed Cognitive Control Networks
University of Alabama at Birmingham
NCT05927974
Assessing Cognitive Decline at Home
Stanford University
NCT06704971
OCT Angiography and NRAI in Dementia
Oregon Health and Science University
NCT03761381
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
Brigham and Women's Hospital
NCT06489548
ToolBox Detect: Low Cost Detection of Cognitive Decline in Primary Care Settings
Northwestern University
NCT04852601
Aspirin in Reducing Events in the Elderly-Extension (ASPREE-XT)
Anne Murray
NCT07224347
Sex-specific Risk Factors and Trajectories of Blood Biomarkers for Alzheimer's Disease and Related Dementias
Anne Murray
NCT07224139
Changing Talk Online Training (CHATO) National Trial
University of Kansas Medical Center
NCT04610944
The Brain Health Study: A Pragmatic, Patient-Centered Trial
Kaiser Permanente
NCT05356702
Screening for Memory Studies
John Wesson Ashford Jr
NCT01123018
Biomarkers for Vascular Contributions to Cognitive Impairment and Dementia Consortium
Massachusetts General Hospital
NCT06284213
A Study of Different Donanemab (LY3002813) Dosing Regimens in Adults With Early Alzheimer's Disease (TRAILBLAZER-ALZ 6)
Eli Lilly and Company
NCT05738486
The BRAIN Intensive Care Unit (ICU) Study: Bringing to Light the Risk Factors
Vanderbilt University Medical Center
NCT00392795
Minnesota Inclusive LTSS for LGBTQ Seniors
University of Minnesota
NCT05530590
Brain Attack Surveillance in Corpus Christi--Cognitive (BASIC-Cognitive)
University of Michigan
NCT03403257
ACHIEVE Brain Health Follow-Up Study
Johns Hopkins University
NCT05532657
BRINK (BRain In Kidney Disease) Memory Study 2.0
Anne Murray
NCT04975464
A Study of JNJ-63733657 in Participants With Early Alzheimer's Disease
Janssen Research & Development
NCT04619420
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
Washington University School of Medicine
NCT01760005
Quality Improvement and Clinical Utility PrecivityAD2(TM) Clinician Survey
C2N Diagnostics
NCT06025877
A Study of Caregiver Connections Via Technology in Dementia
Mayo Clinic
NCT05779839
A Study to Evaluate the Efficacy and Safety of MK-1167 in Participants With Alzheimer's Disease Dementia (MK-1167-008)
Merck Sharp & Dohme
NCT06721156
Reducing Risk of Dementia Through Deprescribing
Indiana University
NCT04270474
The PorchLight Project
University of Minnesota
NCT05550727
PLAN: Dementia Literacy Education and Navigation for Korean Elders With Probable Dementia and Their Caregivers
Johns Hopkins University
NCT03909347
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 10 |
| Phase 2 | 19 |
| Phase 3 | 10 |
| Phase 4 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Dementia records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dementia trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dementia page
202 registered trials, 79 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 79 Dementia trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of Washington sponsors the most Dementia trials on record, review their full trial history before evaluating a specific study. See University of Washington's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dementia condition card totals 202 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.